toripalimab + lenvatinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for toripalimab + lenvatinib, covering 2023-03-29 to 2023-03-29. Get the full timeline:
Most recent: Clinical Trial Update: Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers [Phase 2]